ANEBULO PHARMACEUTICALS INC's ticker is ANEB and the CUSIP is 034569103. A total of 11 filers reported holding ANEBULO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,219,614 | +30.0% | 399,219 | 0.0% | 0.09% | +41.5% |
| Q2 2023 | $938,165 | -19.0% | 399,219 | 0.0% | 0.06% | -14.5% |
| Q1 2023 | $1,157,735 | +19.7% | 399,219 | 0.0% | 0.08% | +38.2% |
| Q4 2022 | $967,587 | -13.5% | 399,219 | 0.0% | 0.06% | -15.4% |
| Q3 2022 | $1,118,000 | -46.1% | 399,219 | 0.0% | 0.06% | -36.3% |
| Q2 2022 | $2,076,000 | -26.5% | 399,219 | 0.0% | 0.10% | -32.9% |
| Q1 2022 | $2,826,000 | +12.9% | 399,219 | -1.9% | 0.15% | +2.0% |
| Q4 2021 | $2,503,000 | -8.2% | 407,059 | -2.3% | 0.15% | -38.9% |
| Q3 2021 | $2,728,000 | -6.6% | 416,546 | -2.8% | 0.24% | -18.9% |
| Q2 2021 | $2,922,000 | – | 428,500 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 5,066,290 | $15,477,516 | 11.03% |
| LVW Advisors, LLC | 672,331 | $2,053,972 | 0.42% |
| Praetorian PR LLC | 177,292 | $541,627 | 0.28% |
| Nantahala Capital Management | 511,073 | $1,561,328 | 0.13% |
| MANGROVE PARTNERS IM, LLC | 399,219 | $1,219,614 | 0.09% |
| Ikarian Capital, LLC | 157,862 | $503,580 | 0.06% |
| Tower Research Capital LLC (TRC) | 20,851 | $63,700 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,978 | $57,978 | 0.00% |
| ROYAL BANK OF CANADA | 48 | $0 | 0.00% |
| VANGUARD GROUP INC | 22,344 | $68,261 | 0.00% |